PKA/CaMK Inhibitor Cocktail
|
Login
|
PKA/CaMK Inhibitor Cocktail
|
Type |
Enzymes |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217672 |
Amount |
1ml |
Available |
|
|
Prostaglandin I2, Sodium Salt (PGI2, Prostacyclin)
|
Login
|
Prostaglandin I2, Sodium Salt (PGI2, Prostacyclin)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217707 |
Amount |
1mg |
Available |
|
|
PTK/PI 3-K/mTOR Inhibitor, PP121(1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, PI 3-K Inhibitor XIII, PI 3-K/mTOR Inhibitor II, VEGFR Tyrosine Kinase Inhibitor XXXII, VEGFR2 Kinase Inhibitor XXX, mTOR Inhibitor VII,
|
Login
|
PTK/PI 3-K/mTOR Inhibitor, PP121(1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, PI 3-K Inhibitor XIII, PI 3-K/mTOR Inhibitor II, VEGFR Tyrosine Kinase Inhibitor XXXII, VEGFR2 Kinase Inhibitor XXX, mTOR Inhibitor VII,
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217722 |
Amount |
5mg |
Available |
|
|
Ras Superfamily GTPases GTP/GDP Binding Antagonist, CID 1067700
|
Login
|
Ras Superfamily GTPases GTP/GDP Binding Antagonist, CID 1067700
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217737 |
Amount |
10mg |
Available |
|
|
RubR1 Activator, GF-15 (2'-Benzyloxy-2'-demethoxygriseofulvin, (2S,6'R)-(7-Chloro-4,6-dimethoxy-benzofuran-3-on)-2-spiro-1'-(2'-benzyloxy-6'-methylcyclohex-2'-en-4'-one), (2S,5'R)-3'-benzyloxy-7-chloro-4,6-dimethoxy-5'-methyl-spiro(benzofuran-2,4'-cyclohe
|
Login
|
RubR1 Activator, GF-15 (2'-Benzyloxy-2'-demethoxygriseofulvin, (2S,6'R)-(7-Chloro-4,6-dimethoxy-benzofuran-3-on)-2-spiro-1'-(2'-benzyloxy-6'-methylcyclohex-2'-en-4'-one), (2S,5'R)-3'-benzyloxy-7-chloro-4,6-dimethoxy-5'-methyl-spiro(benzofuran-2,4'-cyclohe
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217761 |
Amount |
25mg |
Available |
|
|
SB-277011-A Dihydrochloride (SB277011A, SB 277011A, Dopamine D3 Receptor Antagonist, SB-277011-A, SB-277011A)
|
Login
|
SB-277011-A Dihydrochloride (SB277011A, SB 277011A, Dopamine D3 Receptor Antagonist, SB-277011-A, SB-277011A)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217783 |
Amount |
5mg |
Available |
|
|
SC66, Akt Inhibitor XVIII ((2E,6E)-2,6-bis(4-Pyridylmethylene)cyclohexanone)
|
Login
|
SC66, Akt Inhibitor XVIII ((2E,6E)-2,6-bis(4-Pyridylmethylene)cyclohexanone)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217784 |
Amount |
25mg |
Available |
|
|
SCH 23390 Hydrochloride (Dopamine Receptor D1/D5 Antagonist, SCH 23390, (R)-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride, SCH23390, SCH-23390)
|
Login
|
SCH 23390 Hydrochloride (Dopamine Receptor D1/D5 Antagonist, SCH 23390, (R)-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride, SCH23390, SCH-23390)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217785 |
Amount |
10mg |
Available |
|
|
Smoothened Agonist, SAG (N-Methyl-N’-(3-pyridinylbenzyl)-N’-(3-chlorobenzo[b]thiophene-2-carbonyl)-1,4-diaminocyclohexane, SAG1.3 )
|
Login
|
Smoothened Agonist, SAG (N-Methyl-N’-(3-pyridinylbenzyl)-N’-(3-chlorobenzo[b]thiophene-2-carbonyl)-1,4-diaminocyclohexane, SAG1.3 )
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217797 |
Amount |
1mg |
Available |
|
|
SN50, NF-kB Cell-Permeable Inhibitor Peptide (AAVALLPAVLLALLAPVQRKRQKLMP)
|
Login
|
SN50, NF-kB Cell-Permeable Inhibitor Peptide (AAVALLPAVLLALLAPVQRKRQKLMP)
|
Type |
Enzymes |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217798 |
Amount |
500ug |
Available |
|
|
SNC80 (Delta Opioid Receptor Agonist, SNC80)
|
Login
|
SNC80 (Delta Opioid Receptor Agonist, SNC80)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217799 |
Amount |
10mg |
Available |
|
|
SOD1 Inhibitor, LCS-1 (4,5-dichloro-2-(3-methylphenyl)-3(2H)-pyridazinone, 4,5-dichloro-2-m-tolylpyridazin-3(2H)-one, Superoxide Dismutase 1 Inhibitor, Lung Cancer Screen 1)
|
Login
|
SOD1 Inhibitor, LCS-1 (4,5-dichloro-2-(3-methylphenyl)-3(2H)-pyridazinone, 4,5-dichloro-2-m-tolylpyridazin-3(2H)-one, Superoxide Dismutase 1 Inhibitor, Lung Cancer Screen 1)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217802 |
Amount |
10mg |
Available |
|
|
Survivin Antagonist, S12 (Survivin Inhibitor II, 3-(2-(benzo[d][1,3]dioxol-5-yl)-2-oxoethyl)-5-bromo-3-hydroxyindolin-2-one)
|
Login
|
Survivin Antagonist, S12 (Survivin Inhibitor II, 3-(2-(benzo[d][1,3]dioxol-5-yl)-2-oxoethyl)-5-bromo-3-hydroxyindolin-2-one)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217816 |
Amount |
10mg |
Available |
|
|
Survivin Inhibitor III, LLP-3 (Survivin-Ran Interaction Blocker, LLP3, 4-(3,5-bis(Benzyloxy)phenyl)-6-(5-chloro-2-hydroxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile)
|
Login
|
Survivin Inhibitor III, LLP-3 (Survivin-Ran Interaction Blocker, LLP3, 4-(3,5-bis(Benzyloxy)phenyl)-6-(5-chloro-2-hydroxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217817 |
Amount |
10mg |
Available |
|
|
Survivin Inhibitor, YM155 (Survivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor)
|
Login
|
Survivin Inhibitor, YM155 (Survivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217818 |
Amount |
10mg |
Available |
|
|
Synuclein, alpha, Control Peptide (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Login
|
Synuclein, alpha, Control Peptide (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Type |
Peptides |
Clone |
|
Specific against |
Hu
|
Appl. |
ELISA |
Host |
|
Item no. |
USB-217822 |
Amount |
100ug |
Available |
|
|
Synuclein, alpha, Human, aa1-95 (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Login
|
Synuclein, alpha, Human, aa1-95 (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217823 |
Amount |
500ug |
Available |
|
|
Synuclein, alpha, Human, aa61-140 (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Login
|
Synuclein, alpha, Human, aa61-140 (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217824 |
Amount |
500ug |
Available |
|
|
Synuclein, alpha, Recombinant, Human (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Login
|
Synuclein, alpha, Recombinant, Human (SNCA, MGC110988, Alpha-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, NACP, PARK1)
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217825 |
Amount |
500ug |
Available |
|
|
Tie2/Trk Dual Inhibitor (Tie2 Inhibitor IV, Trk Inhibitor VII)
|
Login
|
Tie2/Trk Dual Inhibitor (Tie2 Inhibitor IV, Trk Inhibitor VII)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217834 |
Amount |
10mg |
Available |
|
|
TLR1/TLR2 Antagonist, CU-CPT22 (Hexyl-3,4,6-trihydroxy-2-methoxy-5-oxo-5H-benzo[7]annulene-8-carboxylate)
|
Login
|
TLR1/TLR2 Antagonist, CU-CPT22 (Hexyl-3,4,6-trihydroxy-2-methoxy-5-oxo-5H-benzo[7]annulene-8-carboxylate)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217836 |
Amount |
10mg |
Available |
|
|
TMEM16A Activator, Eact (3,4,5-trimethoxy-N-(2-methoxyethyl)-N-(4-phenylthiazol-2-yl)benzamide, ANO1 Activator)
|
Login
|
TMEM16A Activator, Eact (3,4,5-trimethoxy-N-(2-methoxyethyl)-N-(4-phenylthiazol-2-yl)benzamide, ANO1 Activator)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217839 |
Amount |
10mg |
Available |
|
|
TMEM16A Inhibitor, T16Ainh-A01 (2-(5-ethyl-4-hydroxy-6-methylpyrimidin-2-ylthio)-N-(4-(4-methoxyphenyl)thiazol-2-yl)acetamide, ANO1 Inhibitor, T16Ainh-A01, TMEM16A Antagonist, T16Ainh-A01)
|
Login
|
TMEM16A Inhibitor, T16Ainh-A01 (2-(5-ethyl-4-hydroxy-6-methylpyrimidin-2-ylthio)-N-(4-(4-methoxyphenyl)thiazol-2-yl)acetamide, ANO1 Inhibitor, T16Ainh-A01, TMEM16A Antagonist, T16Ainh-A01)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217840 |
Amount |
5mg |
Available |
|
|
Tumor Necrosis Factor, Recombinant, Human (TNF, TNF-alpha, TNFA, TNF-a, Cachectin, DIF, Tumor Necrosis Factor Ligand Superfamily Member 2, TNFSF2)
|
Login
|
Tumor Necrosis Factor, Recombinant, Human (TNF, TNF-alpha, TNFA, TNF-a, Cachectin, DIF, Tumor Necrosis Factor Ligand Superfamily Member 2, TNFSF2)
|
Type |
Cytokines and Growth Factors |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217858 |
Amount |
50ug |
Available |
|
|
UBP310 (GluK1/GluK3 Antagonist, UBP310, (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione, UBP-310, UBP 310)
|
Login
|
UBP310 (GluK1/GluK3 Antagonist, UBP310, (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione, UBP-310, UBP 310)
|
Type |
Biochemicals |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
USB-217862 |
Amount |
10mg |
Available |
|
|